Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Cash on Hand 2012–2025
Crescent Biopharma, Inc. annual/quarterly cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Crescent Biopharma, Inc. cash on hand for the quarter ending December 31, 2025 were 213.2M, a 410.12% increase year-over-year.
- Crescent Biopharma, Inc. cash on hand for 2025 were 213.2M, a 410.12% increase from 2023.
- Crescent Biopharma, Inc. cash on hand for 2023 were 41.8M, a 12.70% decrease from 2022.
- Crescent Biopharma, Inc. cash on hand for 2022 were 47.9M, a 46.96% decrease from 2021.
- Crescent Biopharma, Inc. cash on hand for 2021 were 90.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Crescent Biopharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $213 |
| 2023 | $42 |
| 2022 | $48 |
| 2021 | $90 |
| 2020 | $137 |
| 2016 | $40 |
| 2015 | $47 |
| 2014 | $55 |
| 2013 | $2 |
| Crescent Biopharma, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $213 |
| 2023-12-31 | $42 |
| 2022-12-31 | $48 |
| 2021-12-31 | $90 |
| 2020-12-31 | $137 |
| 2016-12-31 | $40 |
| 2015-12-31 | $47 |
| 2014-12-31 | $55 |
| 2013-12-31 | $2 |
Crescent Biopharma, Inc. Cash on Hand — FAQ
Crescent Biopharma, Inc. (CBIO) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's cash on hand history?
The chart and table above show Crescent Biopharma, Inc.'s cash on hand by year and by quarter, including the growth rate.